Use of VWF-stabilized FVIII and non-FVIII VWF formulations for extravascular administration in the treatment and prophylactic treatment of bleeding disorders

摘要

The present invention relates to the use of von Willebrand Factor (VWF) preparations or of a VWF preparation in combination with coagulation Factor VIII (FVIII) for extravascular administration in the therapy and prophylactic treatment of bleeding disorders.